Inhibition of pancreatic lipase
The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PEARSON, JEFFREY PETER DETTMAR, PETER WILLIAM WILCOX, MATTHEW DAVID BROWNLEE, LAIN ANDREW RICHARDSON, JOHNATHAN CRAIG |
| description | The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2010322840BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2010322840BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2010322840BB23</originalsourceid><addsrcrecordid>eNrjZJD3zMvITMosyczPU8hPUyhIzEsuSk0syUxWyMksSCxO5WFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGBsZGRhYmBk5ORsZEKgMAAIYmJg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibition of pancreatic lipase</title><source>esp@cenet</source><creator>PEARSON, JEFFREY PETER ; DETTMAR, PETER WILLIAM ; WILCOX, MATTHEW DAVID ; BROWNLEE, LAIN ANDREW ; RICHARDSON, JOHNATHAN CRAIG</creator><creatorcontrib>PEARSON, JEFFREY PETER ; DETTMAR, PETER WILLIAM ; WILCOX, MATTHEW DAVID ; BROWNLEE, LAIN ANDREW ; RICHARDSON, JOHNATHAN CRAIG</creatorcontrib><description>The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160512&DB=EPODOC&CC=AU&NR=2010322840B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160512&DB=EPODOC&CC=AU&NR=2010322840B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PEARSON, JEFFREY PETER</creatorcontrib><creatorcontrib>DETTMAR, PETER WILLIAM</creatorcontrib><creatorcontrib>WILCOX, MATTHEW DAVID</creatorcontrib><creatorcontrib>BROWNLEE, LAIN ANDREW</creatorcontrib><creatorcontrib>RICHARDSON, JOHNATHAN CRAIG</creatorcontrib><title>Inhibition of pancreatic lipase</title><description>The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD3zMvITMosyczPU8hPUyhIzEsuSk0syUxWyMksSCxO5WFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGBsZGRhYmBk5ORsZEKgMAAIYmJg</recordid><startdate>20160512</startdate><enddate>20160512</enddate><creator>PEARSON, JEFFREY PETER</creator><creator>DETTMAR, PETER WILLIAM</creator><creator>WILCOX, MATTHEW DAVID</creator><creator>BROWNLEE, LAIN ANDREW</creator><creator>RICHARDSON, JOHNATHAN CRAIG</creator><scope>EVB</scope></search><sort><creationdate>20160512</creationdate><title>Inhibition of pancreatic lipase</title><author>PEARSON, JEFFREY PETER ; DETTMAR, PETER WILLIAM ; WILCOX, MATTHEW DAVID ; BROWNLEE, LAIN ANDREW ; RICHARDSON, JOHNATHAN CRAIG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2010322840BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PEARSON, JEFFREY PETER</creatorcontrib><creatorcontrib>DETTMAR, PETER WILLIAM</creatorcontrib><creatorcontrib>WILCOX, MATTHEW DAVID</creatorcontrib><creatorcontrib>BROWNLEE, LAIN ANDREW</creatorcontrib><creatorcontrib>RICHARDSON, JOHNATHAN CRAIG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PEARSON, JEFFREY PETER</au><au>DETTMAR, PETER WILLIAM</au><au>WILCOX, MATTHEW DAVID</au><au>BROWNLEE, LAIN ANDREW</au><au>RICHARDSON, JOHNATHAN CRAIG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibition of pancreatic lipase</title><date>2016-05-12</date><risdate>2016</risdate><abstract>The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2010322840BB2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Inhibition of pancreatic lipase |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A11%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PEARSON,%20JEFFREY%20PETER&rft.date=2016-05-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2010322840BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |